A Retrospective Cohort Study to Assess Drug Utilisation and Long-Term Safety of Galcanezumab in US Patients in the Course of Routine Clinical Care (I5Q-MC-B001)

First published 17/01/2019

Last updated 21/03/2024

EU PAS number:

EUPAS27597

Study

Ongoing

Documents

Study protocol

Initial protocol

I5Q-MC-B001 Protocol v1_Redacted

English (735 KB - PDF)View document

Updated protocol

I5Q-MC-B001_Galcanezumab_US_LongTermSafety_Protocol_Amend(b)_Redacted

First published: 22/02/2024

English (804.54 KB - PDF)View document

Study results

Study report

Other information

Secondary tabs